Modes of Action of a Novel c-MYC Inhibiting 1,2,4-Oxadiazole Derivative in Leukemia and Breast Cancer Cells

The c-MYC oncogene regulates multiple cellular activities and is a potent driver of many highly aggressive human cancers, such as leukemia and triple-negative breast cancer. The oxadiazole class of compounds has gained increasing interest for its anticancer activities. The aim of this study was to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Min, Boulos, Joelle C., Omer, Ejlal A., Klauck, Sabine M., Efferth, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419799/
https://www.ncbi.nlm.nih.gov/pubmed/37570631
http://dx.doi.org/10.3390/molecules28155658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419799/
https://www.ncbi.nlm.nih.gov/pubmed/37570631
http://dx.doi.org/10.3390/molecules28155658

Ejemplares similares